Anti-LEPR/ CD295/ LEP-RD functional antibody

Anti-LEPR/ CD295/ LEP-RD functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LEPR/LEPR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T17163-Ab-1/ GM-Tg-hg-T17163-Ab-2Anti-Human LEPR monoclonal antibodyHuman
GM-Tg-rg-T17163-Ab-1/ GM-Tg-rg-T17163-Ab-2Anti-Rat LEPR monoclonal antibodyRat
GM-Tg-mg-T17163-Ab-1/ GM-Tg-mg-T17163-Ab-2Anti-Mouse LEPR monoclonal antibodyMouse
GM-Tg-cynog-T17163-Ab-1/ GM-Tg-cynog-T17163-Ab-2Anti-Cynomolgus/ Rhesus macaque LEPR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T17163-Ab-1/ GM-Tg-felg-T17163-Ab-2Anti-Feline LEPR monoclonal antibodyFeline
GM-Tg-cang-T17163-Ab-1/ GM-Tg-cang-T17163-Ab-2Anti-Canine LEPR monoclonal antibodyCanine
GM-Tg-bovg-T17163-Ab-1/ GM-Tg-bovg-T17163-Ab-2Anti-Bovine LEPR monoclonal antibodyBovine
GM-Tg-equg-T17163-Ab-1/ GM-Tg-equg-T17163-Ab-2Anti-Equine LEPR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T17163-Ab-1/ GM-Tg-hg-T17163-Ab-2; GM-Tg-rg-T17163-Ab-1/ GM-Tg-rg-T17163-Ab-2;
GM-Tg-mg-T17163-Ab-1/ GM-Tg-mg-T17163-Ab-2; GM-Tg-cynog-T17163-Ab-1/ GM-Tg-cynog-T17163-Ab-2;
GM-Tg-felg-T17163-Ab-1/ GM-Tg-felg-T17163-Ab-2; GM-Tg-cang-T17163-Ab-1/ GM-Tg-cang-T17163-Ab-2;
GM-Tg-bovg-T17163-Ab-1/ GM-Tg-bovg-T17163-Ab-2; GM-Tg-equg-T17163-Ab-1/ GM-Tg-equg-T17163-Ab-2
Products NameAnti-LEPR monoclonal antibody
Formatmab
Target NameLEPR
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LEPR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    BiosimilarGMP-Bios-ab-343Pre-Made Mibavademab biosimilar, Whole mAb, Anti-LEPR Antibody: Anti-CD295/OB-R/OBR therapeutic antibody
    Target AntigenGM-Tg-g-T17163-Ag-1Recombinant multi-species LEPR/ CD295/ LEP-RD protein


    Target information

    Target IDGM-T17163
    Target NameLEPR
    Gene ID3953,16847,24536,574126,450207,101085646,497205,100069504
    Gene Symbol and SynonymsCD295,db,diabetes,Fa,LEP-R,LEPR,Leprb,LEPRD,LEPROT,Modb1,OB-R,OB-RGRP,Ob-RM,obese-like,obl,OBR,ObRb
    Uniprot AccessionP48357,Q62959,Q9MYL0
    Uniprot Entry NameLEPR_HUMAN,LEPR_MACMU,LEPR_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target, INN Index
    DiseaseProstate Cancer
    Gene EnsemblENSG00000116678
    Target ClassificationN/A

    The target: LEPR, gene name: LEPR, also named as CD295, LEP-RD, OB-R, OBR, LEPR. The protein encoded by this gene belongs to the gp130 family of cytokine receptors that are known to stimulate gene transcription via activation of cytosolic STAT proteins. This protein is a receptor for leptin (an adipocyte-specific hormone that regulates body weight), and is involved in the regulation of fat metabolism, as well as in a novel hematopoietic pathway that is required for normal lymphopoiesis. Mutations in this gene have been associated with obesity and pituitary dysfunction. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. It is noteworthy that this gene and LEPROT gene (GeneID:54741) share the same promoter and the first 2 exons, however, encode distinct proteins (PMID:9207021).[provided by RefSeq, Nov 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.